Norwegian researchers report that snus users had lower risks for gastroesophageal reflux symptoms (GERS) than never users (abstract here). This builds on Swedish findings of six years ago that snus…
Publishing a study of tobacco-specific nitrosamines in American smokeless tobacco products (abstracthere), Dorothy Hatsukami and colleagues at the University of Minnesota called for the FDA to issue “regulations…to reduce levels of…NNK and NNN in smokeless tobacco products to the lowest levels possible.” The authors make illogical and unscientific claims in their article and media interviews (here).
[First published Sept. 30 in The Oklahoman.] A quit-smoking strategy with “the potential to save millions of lives” will be the subject of an Oklahoma legislative hearing Wednesday. At issue…